Among them, AZD8055 inhibits both mTOR complexes and has shown to inhibit tumor growth [51] and induce ACD in hepatocellular carcinoma cell lines [52], but it is also capable of limiting tumor growth through induction of apoptosis and cell cycle arrest [82]. Here, MTOR is linked to neoplasm.